Stock Price Quote

SAMRAT PHARMACHEM LTD.

NSE : NABSE : 530125ISIN CODE : INE103E01016Industry : Pharmaceuticals & DrugsHouse : Private
BSE366.251.15 (+0.31 %)
PREV CLOSE ( ) 365.10
OPEN PRICE ( ) 355.10
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2377
TODAY'S LOW / HIGH ( )353.40 374.60
52 WK LOW / HIGH ( ) 320604.3
NSE
This Company is not listed in NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1992
Management Info
Lalit Mehta - Chairman Lalit Mehta - Managing Director
Registered Office

Address Plot No A2 / 3445,G I D C Phase 4,Opp. P C I,
Ankleshwar,
Gujarat-393002

Phone 07045456789 / 07046456789

Email contact@samratpharmachem.in

Website www.samratpharmachem.com

Registrars Details
Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, Ahmedabad, Vadodara

NEWS

18Apr Samrat Pharmachem informs about compli
In pursuance of Regulation 40(9), (10) of SEBI (Listing Obligations and..
23Nov Samrat Pharmachem informs about newspa
As per requirement of SEBI (Listing Obligations and Disclosure Requireme..
18Sep Samrat Pharmachem informs about press
Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosur..
08Sep Samrat Pharmachem informs about record
Samrat Pharmachem has informed that the Company has fixed Monday, Septem..
09Aug Samrat Pharmachem informs about loss o
Samrat Pharmachem has informed that it enclosed the details of loss of s..

Financials

in Millions
QTR Dec 23 ANNUAL 23
Net Profit3.44000000000003166.31
Gross Profit 1.41000000000003 225.31
Operating Profit 5.34000000000003244.06
Net Sales 616.743106.46

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Bharat Parenterals (BSE)
peergroup  1455.20 (10.00%)
M.Cap ( in Cr)846.88
Solara Active Pharma (BSE)
peergroup  551.45 (16.32%)
M.Cap ( in Cr)1985.01
Abbott India (BSE)
peergroup  26131.85 (0.29%)
M.Cap ( in Cr)55528.36
Windlas Biotech (BSE)
peergroup  555.05 (6.97%)
M.Cap ( in Cr)1154.42
Concord Biotech (BSE)
peergroup  1595.25 (1.05%)
M.Cap ( in Cr)16688.90

Shareholding Pattern

PROMOTERS 48.64%
NON-INSTITUTION 48.13%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

About Samrat Pharmachem Ltd.

Samrat Pharmachem Ltd. was incorporated in the year 1992. Its today's share price is 366.25. Its current market capitalisation stands at Rs 113.16 Cr. In the latest quarter, company has reported Gross Sales of Rs. 3106.46 Cr and Total Income of Rs.3111.24 Cr. The company's management includes Nishant Kankaria, Renu Dharod, Samir Kothary, Mahendra Pipalia, Megh Mehta, Rajesh Mehta, Lalit Mehta, Lalit Mehta.

It is listed on the BSE with a BSE Code of 530125 , NSE with an NSE Symbol of and ISIN of INE103E01016. It's Registered office is at Plot No A2 / 3445,G I D C Phase 4,Opp. P C IAnkleshwar-393002, Gujarat. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Shah & Savla, Shah & Savla LLP, Shah, Shah & Shah

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.